Press Releases

IR Mobile SiteTear sheetEmail pagePDF viewPrint viewRSS FeedsEmail AlertSocial Media Sharing


Year:
Notify me when new press releases are posted to this site.
Press Releases
3/07/2011Cubist Pharmaceuticals Board of Directors Names Kenneth Bate Non-Executive Chair of the Board
3/01/2011Cubist Pharmaceuticals to Present at March Investor Conference
2/08/2011Cubist Pharmaceuticals to Present at February Investor Conference
1/20/2011Cubist Pharmaceuticals Reports 2010 Fourth Quarter and Full Year Earnings
1/10/2011Cubist Pharmaceuticals Announces Full Year 2010 Revenues: Total Net Revenues of $636 Million; U.S. Net Product Revenues of $600 Million
1/03/2011Cubist Pharmaceuticals and the New England Patriots Radio Network Honor Lowell, Ma Science Teacher
12/14/2010Cubist Pharmaceuticals Revises 2010 Net Revenue Guidance
12/08/2010Cubist Pharmaceuticals to Present at December Investor Conference
12/06/2010Cubist Pharmaceuticals Files Citizen Petition with Food and Drug Administration
12/01/2010Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of CUBICIN
11/08/2010The Boston Globe Names Cubist to Top Places to Work 2010
10/26/2010Cubist Pharmaceuticals to Present at November Investor Conferences
10/25/2010Cubist Completes Offering of $450 Million of Convertible Senior Notes
10/19/2010Cubist Prices $400 Million of Convertible Senior Notes
10/18/2010Cubist Announces Offering of Convertible Senior Notes
10/14/2010Cubist Pharmaceuticals 3Q10 Total Net Revenues Up 13% to $162.1 Million
9/30/2010Cubist Pharmaceuticals to Participate in Panel Discussion at Citi’s 5th Annual Biotech Day
9/13/2010Cubist Pharmaceuticals to Host Product Pipeline Investor and Analyst Event
9/10/2010Cubist Pharmaceuticals’ Antibiotic Programs Featured in 47 Presentations at 50th ICAAC
9/08/2010Cubist Pharmaceuticals Prepares for Continued Growth
 
 Source: SNL Financial LC 
Rows 81 through 100 of 408 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Copyright 2013, © SNL Financial LC  Terms of Use